• Zyfas Pharma Private Limited

© 2019 by Zyfas Medical Co.

                    Singapore & Malaysia

Contact Us: 

Singapore +65 6275 7757

Malaysia +607-354-4766

September Feature: Medicurtain by Shin Poong

September 26, 2018

 

MEDICURTAIN is intended to be injected after open, conservative and laparoscopic surgery in hysteroscopic, abdominal, spinal, thyroid, nasal/sinus, obstetrics and gynecological surgeries to reduce postoperative adhesions. 

 

  • Medicurtain is made of an optimal combination of 2 biocompatible material: 

 

  1. HA (Sodium Hyaluronate) - Creates a physical barrier which prevents adhesion formation

  2. HES (Hydroxyethylstarch) - Inhibits blood clot formation which then reduces the risk of adhesion occurrence 

 

  • Medicurtain provides a reliable barrier that gives adhesion resistant mesothelial cells enough time to regenerate or recover after surgery or as a result of injury

 

 

Click here for more information!

Share on Facebook
Share on Twitter
Please reload